Trial Profile
A Randomized, Double-blind, Active and Placebo Controlled Trial to Compare the Relative Analgesic Efficacy and Safety of a Single Intravenous Dose of ORG 28611 3 mcg/kg, Morphine Sulfate 0.12 mg/kg, and Placebo in Patients Experiencing Moderate to Severe Pain After Dental Impaction Surgery
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Morphine (Primary) ; ORG 28611 (Primary)
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 15 Nov 2008 New trial record.